# An Observational Study of NeoRecormon (Epoetin Beta) in Cancer Patients With Anemia (FAST)

> **NCT01168349** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 1060 (actual)

## Conditions studied

- Anemia, Neoplasms

## Interventions

- **DRUG:** epoetin beta [NeoRecormon]

## Key facts

- **NCT ID:** NCT01168349
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 1060 (ACTUAL)
- **Last updated:** 2015-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01168349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01168349, "An Observational Study of NeoRecormon (Epoetin Beta) in Cancer Patients With Anemia (FAST)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01168349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*